Form 4 for ELV Elevance Health
Accepted 2023-10-26 00:00:00 ET · period of report 2023-10-24 · accession 0001156039-23-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-26 | 2023-10-24 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale | $454.35 | -64 | 2,842 | -2% | -$29.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-24 | S | D | 64 | $454.35 | 2,842 | D | — | — | (F1) Balance includes 7.99 shares acquired on March 24, 2023, 7.93 shares acquired on June 23, 2023 and 7.90 shares acquired on September 22, 2023 through a dividend reinvestment plan. |